Skip to search.
 FTSE 100 Down 0.03%

Kite Pharma, Inc. (KITE)

-NasdaqGS
54.57 Down 0.36(0.66%) 23 Sep 21:00
|After Hours: : 54.61 Up 0.04 (0.07%) 24 Sep 00:47
Prev Close:54.93
Open:54.68
Bid:54.45 x 100
Ask:56.00 x 1000
1y Target Est:71.73
Beta:N/A
Earnings Date:10 Nov - 14 Nov (Est.)
Day's Range:53.30 - 55.05
52wk Range:38.41 - 89.84
Volume:1,048,751
Avg Vol (3m):830,870
Market Cap:2.71b
P/E (ttm):N/A
EPS (ttm):-3.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for KITE at this time.

Comparison

Symbol% ChgMkt Cap
KITEDown 0.66%2.71b
PFEUp 0.32%207.81b
CELGDown 1.03%84.82b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):136.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-5.82
Quarterly EPS Est (Sep-16) :-1.62
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback